These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4725196)

  • 1. Synthesis and pharmacological activity of 1-(arylsulfonyl)-3,5-dialkyl-s-triazine-2,4,6-(1H,3H,5H)-triones.
    Holcomb GN; Klemm LA; Silhavy TJ; Counsell RE
    J Pharm Sci; 1973 Aug; 62(8):1379-81. PubMed ID: 4725196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Derivatives of diamino-1,3,5-triazine. II. Synthesis of some derivative of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I; Pomarnacka E; Kamiński Z
    Acta Pol Pharm; 1980; 37(6):607-13. PubMed ID: 7293805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diamino-1,3,5-triazine derivatives. IV. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4-(5-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Rogulski J; Pacanis A
    Acta Pol Pharm; 1983; 40(5-6):537-44. PubMed ID: 6677069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diamino-1,3,5-triazine derivatives. V. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Kamiński Z; Pacanis A; Rogulski J
    Acta Pol Pharm; 1983; 40(5-6):545-9. PubMed ID: 6677070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diamino-1,3,5-triazine derivatives. VI. Synthesis and hypoglycemic properties of various 6-amino-2-arylo-1,2-dihydro-4-3(3,5,5-trimethylo-2-pyra zolino)-1,3,5-t riazine].
    Gajewski F; Pacanis A; Rogulski J
    Acta Pol Pharm; 1984; 41(1):1-4. PubMed ID: 6496132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diamino-1,3,5 triazine derivatives. VII. Synthesis and various pharmacological properties of 2- amino-4-(3-aminopropyl)-6-(3,5,5-trimethyl- 2-pyrazoline)-1,3,5-triazine].
    Brzozowski Z; Pomarnacka E; Filczewski M; Kosmala M; Oledzka K
    Acta Pol Pharm; 1987; 44(6):481-5. PubMed ID: 3454111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of diamino-1,3,5-triazine. I. Synthesis of some derivatives of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I
    Acta Pol Pharm; 1980; 37(6):601-5. PubMed ID: 7293804
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral agents. 5H-as-Triazino(5,6-b) indoles.
    Gladych JM; Hornby R; Hunt JH; Jack D; Boyle JJ; Ferlauto RJ; Haff RF; Kormendy CG; Stanfield FJ; Stewart RC
    J Med Chem; 1972 Mar; 15(3):277-81. PubMed ID: 4333824
    [No Abstract]   [Full Text] [Related]  

  • 9. [General pharmacological studies with HB 419].
    Pfaff W; Bänder A; Starey F; Hardebeck K; Ritter K; Wohlfarth A
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1378-81. PubMed ID: 4390511
    [No Abstract]   [Full Text] [Related]  

  • 10. Cis-1-[(2-piperidinocyclohexyl)carbonyl]-piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL
    J Med Chem; 1971 Jan; 14(1):54-6. PubMed ID: 5539748
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858
    [No Abstract]   [Full Text] [Related]  

  • 12. Central nervous system, antidiuretic, and some other activities of pyrazoles.
    Garg HG
    J Med Chem; 1972 Apr; 15(4):446-7. PubMed ID: 4336321
    [No Abstract]   [Full Text] [Related]  

  • 13. [New substituted s-triazines of possible pharmacological importance].
    Sciortino T; Maurich V; Gratton S
    Boll Chim Farm; 1977 Nov; 116(11):637-43. PubMed ID: 615638
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 15. A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonists.
    Guo Z; Wu D; Zhu YF; Tucci FC; Pontillo J; Saunders J; Xie Q; Struthers RS; Chen C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):693-8. PubMed ID: 15664839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
    Hasselblatt A; Panten U; Poser W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and hypoglycemic properties of the new derivatives of 4-(2-aminoethyl)benzenesulfonamide and 1,2-dihydro-1,3,5-triazine].
    Gajewski F
    Acta Pol Pharm; 1982; 39(5-6):485-8. PubMed ID: 7171018
    [No Abstract]   [Full Text] [Related]  

  • 18. 4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
    Hester JB; Rudzik AD; Keasling HH; Veldkamp W
    J Med Chem; 1970 Jan; 13(1):23-6. PubMed ID: 5460894
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemic cyclic amidines.
    Barsky LI; Bencze WL
    J Med Chem; 1971 Jan; 14(1):40-4. PubMed ID: 5539744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Substituted S-triazines and amidinoureas with potential pharmacological activity].
    Colautti A; Maurich V
    Farmaco Sci; 1973 Jul; 28(7):531-8. PubMed ID: 4718401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.